Financials data is unavailable for this security.
View more
Year on year Lexicon Pharmaceuticals Inc had net income fall 73.74% from a loss of 101.94m to a larger loss of 177.12m despite a 766.19% increase in revenues from 139.00k to 1.20m.
Gross margin | 93.54% |
---|---|
Net profit margin | -4,138.33% |
Operating margin | -4,037.43% |
Return on assets | -72.42% |
---|---|
Return on equity | -136.09% |
Return on investment | -81.77% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Lexicon Pharmaceuticals Inc fell by 23.88m. Cash Flow from Financing totalled 187.96m or 15,611.30% of revenues. In addition the company used 161.90m for operations while cash used for investing totalled 49.94m.
Cash flow per share | -0.7424 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.4938 |
---|---|
Tangible book value per share | 0.3706 |
More ▼
Balance sheet in USDView more
Current ratio | 7.45 |
---|---|
Quick ratio | 7.43 |
Total debt/total equity | 0.5596 |
---|---|
Total debt/total capital | 0.3588 |
More ▼
Growth rates in USD
SmartText is unavailable
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 0.602 |